State Street Corp Eiger Bio Pharmaceuticals, Inc. Transaction History

State Street Corp

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$0.55 - $1.26 $379,622 - $869,679	-690,222 Reduced 82.46%	146,781 $102,000
Q1 2023 May 15, 2023	BUY	$0.89 - $2.52 $24,499 - $69,370	27,528 Added 3.4%	837,003 $753,000
Q4 2022 Feb 14, 2023	BUY	$1.02 - $7.48 $6,503 - $47,692	6,376 Added 0.79%	809,475 $955,000
Q3 2022 Nov 15, 2022	BUY	$6.04 - $9.66 $608,523 - $973,235	100,749 Added 14.34%	803,099 $6.05 Million
Q2 2022 Aug 15, 2022	BUY	$4.99 - $8.96 $738,694 - $1.33 Million	148,035 Added 26.71%	702,350 $4.43 Million

Q1 2022 May 16, 2022	BUY	$3.84 - $9.74 $31,334 - $79,478	8,160 Added 1.49%	554,315 $4.6 Million
Q4 2021 Feb 14, 2022	SELL	$5.12 - $8.19 $48,793 - $78,050	-9,530 Reduced 1.72%	546,155 $2.84 Million
Q3 2021 Nov 15, 2021	BUY	$6.68 - $9.1 $94,114 - $128,209	14,089 Added 2.6%	555,685 $3.71 Million
Q2 2021 Aug 16, 2021	BUY	$7.82 - $9.23 $244,218 - $288,252	31,230 Added 6.12%	541,596 $4.61 Million
Q1 2021 May 17, 2021	BUY	$8.44 - $12.66 $106,276 - $159,414	12,592 Added 2.53%	510,366 $4.52 Million
Q4 2020 Feb 16, 2021	BUY	$7.98 - $12.29 $282,021 - $434,340	35,341 Added 7.64%	497,774 $6.12 Million
Q3 2020 Nov 10, 2020	BUY	$7.96 - $12.42 $20,441 - $31,894	2,568 Added 0.56%	462,433 $3.76 Million
Q2 2020 Aug 14, 2020	BUY	$5.4 - $13.37 $1,706 - $4,224	316 Added 0.07%	459,865 $4.42 Million
Q1 2020 May 11, 2020	BUY	$4.91 - $14.7 $2.26 Million - $6.76 Million	459,549 New	459,549 $3.13 Million

748K

Ticker EIGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,966,800
Market Cap $490M
Description
Eiger BioPharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of targeted therapies for rare and ultra-rare diseases in the United States and internationally. Its lead product candidate is Lonafarnib, an orally bioavailable, small molecule, which is in Phase III clinical trials to ...

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

Stay updated on State Street Corp with notifications on news.